We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INOV
1251
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$631K 0.01%
32,763
+2,791
+9% +$49.5K
MTOR
1252
DELISTED
MERITOR, Inc.
MTOR
$631K 0.01%
31,866
SFIX
1253
Stitch Fix
SFIX
$487M
$630K 0.01%
25,252
+7,931
+46% +$157K
MGNX icon
1254
MacroGenics
MGNX
$259M
$627K 0.01%
22,474
MXL icon
1255
MaxLinear
MXL
$6.95B
$626K 0.01%
29,165
CSGS
1256
DELISTED
CSG Systems International
CSGS
$625K 0.01%
15,105
+1,603
+12% +$73.4K
DDOG icon
1257
Datadog
DDOG
$90.6B
$624K 0.01%
+7,181
New +$437K
TWO
1258
Two Harbors Investment
TWO
$1.26B
$623K 0.01%
+30,926
New +$574K
RVNC
1259
DELISTED
Revance Therapeutics, Inc.
RVNC
$621K 0.01%
25,433
+4,085
+19% +$80.6K
CYTK icon
1260
Cytokinetics
CYTK
$10.2B
$621K 0.01%
26,348
CALM icon
1261
Cal-Maine
CALM
$3.87B
$618K 0.01%
13,890
+1,156
+9% +$49.2K
CTB
1262
DELISTED
Cooper Tire & Rubber Co.
CTB
$616K 0.01%
22,320
ARNC
1263
DELISTED
Arconic Corporation
ARNC
$616K 0.01%
+44,211
New +$518K
PSMT icon
1264
Pricesmart
PSMT
$5.55B
$616K 0.01%
10,206
WSBC icon
1265
WesBanco
WSBC
$4.1B
$616K 0.01%
30,306
+3,155
+12% +$69K
FWRD icon
1266
Forward Air
FWRD
$682M
$615K 0.01%
12,353
+860
+7% +$42.2K
LMNX
1267
DELISTED
Luminex Corp
LMNX
$615K 0.01%
18,901
OSIS icon
1268
OSI Systems
OSIS
$3.77B
$614K 0.01%
8,231
+1,138
+16% +$83.1K
RNST icon
1269
Renasant Corp
RNST
$4B
$614K 0.01%
24,665
+1,758
+8% +$41.7K
VRRM icon
1270
Verra Mobility
VRRM
$731M
$614K 0.01%
59,741
+4,993
+9% +$47.3K
BECN
1271
DELISTED
Beacon Roofing Supply, Inc.
BECN
$614K 0.01%
23,275
MNR
1272
DELISTED
Monmouth Real Estate Investment Corp
MNR
$610K 0.01%
42,125
+3,232
+8% +$41.9K
CENTA icon
1273
Central Garden & Pet Co Class A
CENTA
$2.41B
$610K 0.01%
22,578
TWST icon
1274
Twist Bioscience
TWST
$7.86B
$609K 0.01%
13,445
+1,813
+16% +$65.1K
CCEP icon
1275
Coca-Cola Europacific Partners
CCEP
$47.5B
$608K 0.01%
16,100

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.